Metagenomi Therapeutics Inc (MGX) valuation

MGX: undervalued.

Figures as of the 2026-11-17 close.

How is MGX's intrinsic value calculated?

Its liquidation floor, current assets minus every liability, values the shares at $2.72; the price of $0.63 is 77% below that value. The value is recomputed every night after the US close, from the company's own filings with the SEC and the day's closing price.

Is MGX in the buy zone?

We call it the buy zone when the price is at least 20% below our estimate of intrinsic value. MGX trades at $0.63 against a value of $2.72, a margin of safety of +76.8%: it is in the buy zone. A margin of safety is room for our estimate to be wrong, not a forecast.

At what price would MGX be in the buy zone?

It already is. The buy zone starts at $2.18, which is 20% below our estimate of $2.72, and MGX trades at $0.63.